Precision cancer medicine in Korea
1 Jul 2016
Precision cancer medicine in Korea
New targets in personalised therapy for patients with lung cancer
A global perspective on infections related to cancer
Germline mutations influence risk and recovery throughout life
Genomic interrogation of tumour samples reveals essential targets
Results from the EURO-SKI cessation trial of TKIs in CML
Editor's ASCO 2016 Roundup
Specific mutations in leukaemia patients' blood predicts survival
Super-enhancer analysis reveals subtypes in AML and MDS
Novel therapies for older patients with AML and MDS
Better screening programmes needed for haematological malignancies such as leukaemia
Karyotyping a CLL subset with ibrutinib susceptibility